natgillin/translations-raw huggingface dataset:
Sit in a relaxed, upright position.
Sedite v sproščenem, ravnem položaju.
This may be more common in children than in adults.
To je lahko pogosteje pri otrocih, kot pri odraslih.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Upoštevati je treba uradne smernice za ustrezno uporabo antibakterijskih učinkovin.
Currently available data are described in section 5.1 but no recommendation on posology can be given.
Trenutno razpoložljivi podatki so opisani v poglavju 5.1, vendar priporočil o odmerjanju ni mogoče dati.
This makes it hard to breathe.
To onemogoča dihanje.
Tell your doctor if you have any of these effects.
Povejte svojemu zdravniku, če opazite katerega od teh učinkov.
Use this medicine immediately after preparation.
To zdravilo uporabite takoj po pripravi.
After identical single i.m.
Po identičnem enojnem odmerku i.m.
In healthy subjects 60-70% of a single i.m.
Pri zdravih osebah je bilo 60-70% enkratnega i.m.
Overall, 539 patients (78% adults) were treated in these studies.
V teh študijah so zdravili 539 bolnikov (78 % odraslih).
All these may be signs of an allergic reaction.
To so lahko znaki alergijske reakcije.
However, all mean sputum concentration values were associated with relatively large standard deviations.
Vendar pa so bile vse srednje vrednosti koncentracij v izpljunku povezane z relativno velikimi standardnimi odkloni.
In-use storage times and conditions prior to use are the responsibility of the user.
Za shranjevanje med uporabo in pogoje pred uporabo je odgovoren uporabnik.
The following pack sizes are available:
Na voljo so naslednje velikosti pakiranj:
If you notice that the performance has changed before this time (for instance, if it takes longer to produce a mist, more than 5 minutes), please refer to the Altera Nebuliser instructions for use.
Če opazite, da se delovanje spremeni že pred koncem tega obdobja (če na primer nastajanje meglice traja dalj časa, več kot 5 minut), preberite navodila za uporabo nebulatorja Altera.
Frequencies are defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10) and uncommon (≥ 1/1000 to < 1/100).
Pogostnosti pojavov so opredeljene kot sledi: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10) in občasni (≥ 1/1.000 do < 1/100).
- if you are allergic to aztreonam or any of the other ingredients of this medicine (listed in section 6).
- če ste alergični na aztreonam ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
dose was recovered in the urine by 8 hours, and urinary excretion was essentially complete by 12 hours.
odmerka najti v urinu po 8 urah, izločanje z urinom pa je bilo v glavnem zaključeno po 12 urah.
Use the prepared solution within 8 hours.
Pripravljeno raztopino uporabite v 8 urah.
Reconstitute before use.
Pred uporabo rekonstituirajte.
You will hear one “beep” and the status light will turn green.
Zaslišali boste pisk in statusna lučka se bo spremenila na zeleno.
Recovery data indicate that about 10% of the dose is excreted as this metabolite.
Podatki o izločanju kažejo, da se približno 10% odmerka izloči kot ta presnovek.
Carefully remove (but do not yet discard) the rubber stopper.
Previdno odstranite gumijasti zamašek (vendar ga še ne zavrzite).
or i.v.
ali i.v.
Refer to section 4.4.
Glejte poglavje 4.4.
Do not prepare more than one dose at a time.
Ne pripravite več kot enega odmerka hkrati.
If a case of bronchospasm is suspected to be part of an allergic reaction appropriate measures should be taken (see “allergic reactions” paragraph above).
Če se sumi, da je primer bronhospazma del alergijske reakcije, je treba ustrezno ukrepati (glejte poglavje “Alergijske reakcije” poglavje zgoraj).
This leaflet was last revised in .
Navodilo je bilo nazadnje revidirano dne .
This helps to ensure that you get the proper dose of medicine.
S tem zagotovite pravilni odmerek zdravila.
This pack is not to be sold separately.
Ta paket ni namenjen prodaji kot samostojna enota.
The survival rate during the lactation period was slightly reduced in the offspring of rats that received the highest dose.
Stopnja preživetja v obdobju dojenja je bila nekoliko manjša pri podganjih mladičih, ki so prejemali najvišji odmerek.
doses, the serum concentrations are comparable at 1 hour (1.5 hours from the start of i.v.
so koncentracije v serumu primerljive pri 1 uri (1,5 ure po začetku i.v.
Patients continued on their baseline medications, including macrolide antibiotics.
Bolniki so nadaljevali jemanje izhodiščnih zdravil, vključno z makrolidnimi antibiotiki.
There are no data from the use of aztreonam in pregnant women.
Ni podatkov o uporabi aztreonama pri nosečnicah.
The ampoule is imprinted in English only.
Napis na ampuli je le v angleščini.
The safety and efficacy of Cayston in children younger than 6 years of age have not been established.
Varnost in učinkovitost zdravila Cayston pri otrocih, mlajših od 6 let, še ni nista bili dokazani.
Hold the handset level and place the mouthpiece in your mouth and close your lips around it (Figure 4).
Komplet z nebulatorjem držite ravno, dajte ustnik v usta in okoli njega zaprite ustnice (slika 4).
Patients were required to have been off antipseudomonal antibiotics for at least 28 days before treatment with study drug.
Bolniki niso smeli prejemati antipsevdomonskih antibiotikov najmanj 28 dni pred zdravljenjem s študijskim zdravilom.
When all of the medicine has been delivered, you will hear a tone that means “treatment complete” (2 beeps).
Ko je zdravilo porabljeno, boste slišali zvok, ki pomeni “konec zdravljenja” (2 piska).
What Cayston is and what it is used for
Kaj je zdravilo Cayston in za kaj ga uporabljamo
Powder vial: 4 years.
Viala s praškom: 4 leta Vehikel: 3 leta
Press and hold the On/Off button on the Control Unit for a few seconds.
Pritisnite in nekaj sekund držite gumb za vklop/izklop na kontrolni enoti.
Do not reconstitute more than one dose at a time.
Ne rekonstituirajte več kot enega odmerka hkrati.
infusion), with similar slopes of serum concentrations thereafter.
infundiranja), s podobnimi kasnejšimi nakloni koncentracij v serumu.
Efficacy has not been established in patients with FEV1 > 75% predicted.
Učinkovitosti pri bolnikih z napovedanim odstotkom FEV1 > 75% niso ugotavljali.
If you miss a dose, you can still take all 3 daily doses as long as they are at least 4 hours apart.
Če izpustite odmerek, lahko še vedno uporabite vse 3 dnevne odmerke, če so med njimi vsaj 4-urni časovni presledki.
If you get a rash, tell your doctor immediately because this could mean that you have an allergic reaction to Cayston.
Če dobite izpuščaj, takoj obvestite svojega zdravnika, saj lahko to pomeni alergijsko reakcijo na zdravilo Cayston.
However, due to the uncontrolled nature of the study and concomitant medications no conclusion can be drawn on the sustainability of the observed short term benefit over subsequent courses of treatment.
Vendar zaradi nenadzorovanega poteka študije in sočasne uporabe drugih zdravil, ni mogoče sklepati o trajnosti opaženega kratkoročnega učinka v naslednjih ciklih zdravljenja.
Squeeze out the contents completely into the vial (Figure 2).
Celotno vsebino stisnite v vialo (slika 2).
ESBLs from Class A, B and D beta-lactamases may have activity against aztreonam.
ESBL iz betalaktamaz razredov A, B in D ima lahko dejavnost proti aztreonamu.
If you have ever coughed up blood you should only use Cayston if your doctor thinks the benefit of taking this medicine outweighs the risk of coughing up blood.
Če ste kadar koli izkašljali kri, zdravilo Cayston uporabljajte samo, če zdravnik presodi, da so koristi uporabe tega zdravila večje od tveganj izkašljevanja krvi.
Each treatment takes about 2 to 3 minutes to inhale.
Vsaka uporaba z inhaliranjem traja 2 do 3 minute.
Aztreonam, a monobactam, is only weakly immunogenic.
Aztreonam, monobaktam, je le šibko imunogen.
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM Redno posodobljena poročila o varnosti zdravila (PSUR) Zahteve glede predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
If an allergic reaction to aztreonam does occur, stop administration of the medicinal product and initiate treatment as appropriate.
Če se pojavi alergijska reakcija na aztreonam, takoj nehajte uporabljati zdravilo in uvedite ustrezno zdravljenje.
The dosing in children aged 6 years and older is the same as for adults.
Odmerjanje pri otrocih, starih 6 let in več, je enako kot pri odraslih.
The information that appears on the ampoule is presented below:
Informacije na ampuli so navedene spodaj:
There was no clinically relevant effect of age or sex on the pharmacokinetics of aztreonam.
Klinično pomembnega vpliva starosti ali spola na farmakokinetiko aztreonama ni.
Pharmacotherapeutic group: Antibacterials for systemic use, other beta-lactam antibacterials, ATC code: J01DF01
Farmakoterapevtska skupina: Zdravila za sistemsko zdravljenje bakterijskih infekcij, drugi betalaktamski antibiotiki, oznaka ATC: J01DF01
Other medicines and Cayston
Druga zdravila in zdravilo Cayston
The principal metabolite (SQ26,992) is inactive and is formed by opening of the beta-lactam ring due to hydrolysis.
Glavni presnovek (SQ26,992) je neaktiven in nastane z odprtjem betalaktamskega obroča zaradi hidrolize.
Plasma concentrations
Koncentracije v plazmi
• 28-day pack of Cayston
• 28-dnevni paket zdravila Cayston
Class A betalactamases reported to hydrolyse aztreonam include the VEB type (primarily Southeast Asia), PER type (Turkey), and GES and IBC types (France, Greece, and S. Africa).
Betalaktamaze razreda A, o katerih poročajo, da hidrolizirajo aztreonam, vključujejo tip VEB (primarno Jugovzhodna Azija), tip PER (Turčija) in tipa GES in IBC (Francija, Grčija in J. Afrika).
Doses should be taken at least 4 hours apart.
Odmerke je treba uporabljati z vsaj 4-urnim razmakom.
Patients with Burkholderia cepacia isolated from sputum within the previous 2 years were excluded from the clinical studies.
Bolniki, pri katerih so iz izpljunka izolirali povzročitelja Burkholderia cepacia v roku predhodnih 2 let, so bili izključeni iz kliničnih študij.
Inhalation of nebulised solutions may induce a cough reflex.
Inhaliranje nebuliziranih raztopin lahko povzroči refleks kašlja.
Systemically absorbed aztreonam is eliminated about equally by active tubular secretion and glomerular filtration.
Sistemsko absorbiran aztreonam se približno enakovredno izloči z aktivno tubularno sekrecijo in glomerularno filtracijo.
Do not use this medicine if it has been stored outside a refrigerator for more than 28 days.
Ne uporabljajte tega zdravila, če je bilo shranjeno zunaj hladilnika več kot 28 dni.
The protein binding of aztreonam in plasma is approximately 77% at clinically relevant plasma concentrations.
Vezava aztreonama na beljakovine v plazmi je približno 77% pri klinično pomembnih koncentracijah v plazmi.
For patients taking multiple inhaled therapies, the recommended order of administration is as follows:
Za bolnike, ki uporabljajo več inhalacijskih terapij, se priporoča naslednji vrstni red uporabe:
Additionally, aztreonam-treated patients had fewer hospitalisations due to respiratory events (40 versus 58, p = 0.044) and fewer respiratory events requiring the use of i.v.
Dodatno je bilo v skupini bolnikov, zdravljenih z aztreonamom, manj hospitalizacij zaradi respiratornih dogodkov (40 v primerjavi z 58, p = 0,044) in manj respiratornih dogodkov, zaradi katerih je bila potrebna uporaba i.v.
But, if you cannot use the prepared dose straight away, replace the stopper in the vial and store in a refrigerator.
Če pripravljenega odmerka ne morete takoj uporabiti, vialo ponovno zaprite z zamaškom in jo shranite v hladilnik.
Once treatment is complete, disconnect the Control Unit and take apart the Altera Nebuliser Handset for cleaning and disinfecting.
Ko je zdravljenje zaključeno, izklopite kontrolno enoto in razstavite komplet z nebulatorjem Altera za čiščenje in dezinfekcijo.
Aztreonam for injection has not been formulated for inhalation, and contains arginine, a substance known to cause pulmonary inflammation.
Aztreonam za injiciranje ni bil formuliran za inhaliranje in vsebuje arginin, snov, za katero je znano, da povzroča vnetje pljuč.
If for any reason you must stop the treatment before you have finished, press and hold the On/Off button for one full second.
Če morate zaradi česarkoli zdravljenje prekiniti, preden ste končali, pritisnite in eno sekundo držite gumb za vklop/izklop.
Gently tap the vial against the side of the medicine reservoir if necessary.
Z vialo nežno potrkajte na steno vsebnika za zdravilo, če je potrebno.
What if I need to stop my treatment before I've finished?
Kaj moram narediti za predčasno ustavitev zdravljenja?
Plasma aztreonam concentrations in paediatric patients aged 3 months to < 6 years are comparable to those observed for children > 6 years, adolescents and adults.
Koncentracije aztreonama v plazmi pri pediatričnih bolnikih, starih od 3 mesece do < 6 let, so primerljive s tistimi, ki so jih opazili pri otrocih, starih > 6 let, mladostnikih in odraslih.
There are no clinical data on the use of Cayston in pregnant women, therefore you should not take Cayston during pregnancy unless specifically discussed with your doctor.
Kliničnih podatkov o uporabi zdravila Cayston pri nosečnicah ni, zato zdravila Cayston ne smete uporabljati, razen če ste se o tem natančno pogovorili s svojim zdravnikom.
There are no data on the use of Cayston in patients with severe hepatic impairment (ALT or AST greater than 5 times the upper limit of normal).
Ni podatkov o uporabi zdravila Cayston pri bolnikih s hudo okvaro delovanja jeter (ALT ali AST več kot 5-kratna zgornja meja normale).
The following side effects have been observed after the use of aztreonam for injection, but not after taking Cayston: swelling of the face, lips, tongue and/or throat with difficulty in swallowing or breathing, sweating, skin irritation and flaking, itchy rash, flushing, small red spots and very rarely, blistering of the skin.
Naslednje neželene učinke so opazili po uporabi aztreonama za injiciranje, vendar ne po uporabi zdravila Cayston: otekanje obraza, ustnic, jezika in/ali grla s težavami pri požiranju ali dihanju, potenje, draženje kože in luskavost, srbeč izpuščaj, rdečica, majhne rdeče pike in zelo redko mehurji na koži.
The 1 ml solvent is contained in a plastic ampoule.
1 ml vehikla je v plastični ampuli.
Each of the three doses should be taken by inhalation at least four hours apart, using an Altera Nebuliser Handset.
Vsakega od treh odmerkov je treba uporabiti z inhaliranjem z vsaj štiriurnim časovnim razmakom, z uporabo ustreznega kompleta z nebulatorjem Altera.
You may get a temporary lowering of lung function test result during treatment with Cayston, but this is typically not a lasting effect.
Prehodno se vam med zdravljenjem z zdravilom Cayston lahko znižajo rezultati testa pljučne funkcije, vendar ta učinek običajno ni trajen.
Animal and human data demonstrate low risk of cross-reactivity between aztreonam and beta-lactam antibiotics.
Podatki pri živalih in ljudeh kažejo majhno tveganje navzkrižne reakcije med aztreonamom in betalaktamskimi antibiotiki.
Genotoxicity (Chromosomal aberration and mouse lymphoma mutation assay) studies with aztreonam were negative.
Študije genotoksičnosti (kromosomske aberacije in preskušanje mutacije mišjega limfoma) z aztreonamom so bile negativne.
There are rare reports of Class D beta-lactamases from clinical isolates of P. aeruginosa, OXA-11 (Turkey) and OXA-45 (United States) that hydrolyse aztreonam.
Obstajajo redka poročila o betalaktamazah razreda D iz kliničnih izolatov P. aeruginosa, OXA-11 (Turčija) in OXA-45 (Združene države Amerike), ki hidrolizirajo aztreonam.
If you can't leave a gap of 4 hours just skip the missed dose.
Če presledek med odmerki ne more biti 4-urni, preprosto izpustite pozabljeni odmerek.
The majority of the treatment-emergent isolations were intermittent.
Večina izolacij, ki so se pojavile ob zdravljenju, je bila prehodnih.
bronchodilator mucolytics and lastly, Cayston.
bronhodilatator mukolitiki in nazadnje zdravilo Cayston
Cayston can be used during breast-feeding.
Zdravilo Cayston se lahko uporablja med dojenjem.
Cayston should not be used during pregnancy unless the clinical condition of the woman requires treatment with aztreonam.
Zdravila Cayston ne smete uporabljati pri nosečnicah, razen če klinično stanje nosečnice zahteva zdravljenje z aztreonamom.
Short acting bronchodilators can be taken between 15 minutes and 4 hours and long acting bronchodilators can be taken between 30 minutes and 12 hours prior to each dose of Cayston.
Kratkodelujoče bronhodilatatorje se lahko vzame med 15 minut in 4 ure, dolgodelujoče bronhodilatatorje pa med 30 minut in 12 ur pred vsakim odmerkom zdravila Cayston.
Clinical studies of Cayston did not include Cayston-treated patients aged 65 years and older to determine whether they respond differently from younger patients.
V klinične študije z zdravilom Cayston ni bilo vključenih bolnikov, starih 65 let in starejših, zdravljenih z zdravilom Cayston, da bi se ugotovilo, ali je njihov odziv drugačen kot pri mlajših bolnikih.
During clinical studies of Cayston, isolation of MRSA did not result in worsening of lung function.
V kliničnih študijah z zdravilom Cayston izolacija MRSA ni povzročila poslabšanja pljučne funkcije.
Fifty-nine paediatric patients aged 6 to 17 years were included in the study.
V študijo je bilo vključenih 59 pediatričnih bolnikov, starih 6 do 17 let.
There are rare reports of organisms with metallo-beta-lactamases (MBLs), Class B, that are resistant to aztreonam, VIM-5 (K. pneumoniae and P. aeruginosa - Turkey), VIM-6 (P. putida - Singapore) and VIM-7 (P. aeruginosa - United States), however, it is possible that these organisms were expressing multiple resistance mechanisms and thus a MBL was not responsible for the observed resistance to aztreonam.
Ni poročil o organizmih z metalo-betalaktamazami (MBL), razred B, ki so odporne na aztreonam, VIM-5 (K. pneumoniae in P. aeruginosa - Turčija), VIM-6 (P. putida - Singapur) in VIM-7 (P. aeruginosa - Združene države Amerike), vendar pa je možno, da so ti organizmi izražali multiple mehanizme odpornosti in zato MBL ni bil odgovoren na opazovano odpornost na aztreonam.
When treatment is complete, open the medicine cap to ensure that all medicine has been used.
Po zaključenem zdravljenju odprite pokrov za zdravilo in se prepričajte, da je bilo vso zdravilo porabljeno.
You can breast-feed during treatment with Cayston because the amount of Cayston likely to be passed to your child during breast-feeding will be extremely small.
Med zdravljenjem z zdravilom Cayston lahko dojite, saj je količina zdravila Cayston, ki med dojenjem prehaja na dojenega otroka, izjemno majhna.
The following rare and severe adverse reactions have been reported after parenteral use of other aztreonam containing products: toxic epidermal necrolysis, anaphylaxis, purpura, erythema multiforme, exfoliative dermatitis, urticaria, petechiae, pruritus, diaphoresis.
O naslednjih redkih in resnih neželenih učinkih so poročali po parenteralni uporabi drugih zdravil, ki vsebujejo aztreonam: toksična epidermalna nekroliza, anafilaksa, purpura, multiformni eritem, eksfoliativni dermatitis, urtikarija, petehije, pruritus, diaforeza.
As an inhaled medicine, Cayston could cause you to cough and this could lead to coughing up blood.
Kot zdravilo za inhaliranje lahko zdravilo Cayston povzroči kašelj, kar lahko vodi do izkašljevanja krvi.
Do not use this medicine after the expiry date which is stated on the vial label, solvent ampoule and the carton.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na viali, ampuli z vehiklom in škatli.
The information that appears on the solvent ampoule is provided in English only (see section 6).
Informacije na ampuli z vehiklom so samo v angleščini (glejte poglavje 6).
Cystic fibrosis, also known as mucoviscidosis, is a life-threatening inherited disease that affects the mucus glands of internal organs, especially the lungs, but also of the liver, pancreas, and the digestive system.
Cistična fibroza, znana tudi kot mukoviscidoza, je življenjsko nevarna dedna bolezen, ki prizadene žleze sluznice notranjih organov, zlasti pljuč, pa tudi jeter, trebušne slinavke in prebavnega sistema.
Data from these studies revealed minimal differences in mean plasma aztreonam concentrations between age groups in patients receiving Cayston 3 times a day.
Podatki iz teh študij so razkrili minimalno razliko v srednji koncentraciji aztreonama v plazmi med starostnimi skupinami bolnikov, ki so prejemali zdravilo Cayston 3-krat dnevno.
- Do not use Cayston if it has been stored outside a refrigerator for more than 28 days.
- Ne uporabljajte zdravila Cayston, če je bilo shranjeno zunaj hladilnika več kot 28 dni.
Adverse reactions specifically associated with overdose of Cayston have not been identified.
Neželenih učinkov, povezanih s prevelikim odmerjanjem zdravila Cayston, niso opredelili.
Contents of the pack and other information What Cayston and the solvent contain
Vsebina pakiranja in dodatne informacije Kaj vsebujeta zdravilo Cayston in vehikel
Bronchospasm (an acute reduction of ≥ 15% in FEV1) is a complication associated with nebulised therapies.
Bronhospazem (akutno zmanjšanje ≥ 15 % FEV1) je zaplet, povezan z zdravljenjem z nebulatorjem.
Following administration of aztreonam for injection, aztreonam is excreted in human milk at very low concentrations.
Po uporabi aztreonama za injiciranje se aztreonam izloča v materino mleko v zelo nizkih koncentracijah.
If aerosol mist does not begin to flow, please refer to the Altera manual for information.
Če aerosol ne začne pršeti, preberite priročnik Altera za več informacij.
If you have taken more Cayston than you should, talk to a doctor or pharmacist immediately.
Če ste uporabili večji odmerek zdravila Cayston kot bi smeli, se takoj posvetujte z zdravnikom ali farmacevtom.
Cayston was compared to TNS over three 28-day courses of treatment in a randomised, activecontrolled, multicenter study (GS-US-205-0110).
Zdravilo Cayston so primerjali z RTN v treh 28-dnevnih ciklih zdravljenja v randomizirani, aktivno kontrolirani multricentrični študiji (GS-US-205-0110).
The Kaplan-Meier estimates for this event rate at week 24 were 36% in aztreonamtreated patients and 54% in TNS-treated patients.
Ocena po metodi Kaplan-Meier za ta delež dogodkov v 24. tednu je bila 36 % v skupini, zdravljeni z aztreonamom, in 54 % v skupini, zdravljeni z RTN.
Patients received Cayston at the same frequency (2 or 3 times a day) as they took Cayston or placebo in the randomised studies.
Bolniki so prejemali zdravilo Cayston enako pogosto (2-krat ali 3-krat na dan) kot so prejemali zdravilo Cayston ali placebo v randomiziranih študijah.
- Each dose consists of one vial of Cayston mixed with one ampoule of solvent.
- Vsak odmerek je sestavljen iz ene viale zdravila Cayston, zmešane z eno ampulo vehikla.
Check that your nebuliser works properly before starting your treatment with Cayston.
Preverite, ali nebulator pravilno deluje, preden uporabite zdravilo Cayston.
Inhalation of nebulised solutions may induce a cough reflex which could aggravate underlying conditions (see section 4.4).
Inhaliranje nebuliziranih raztopin lahko povzroči refleks kašlja, ki osnovno bolezen poslabša (glejte poglavje 4.4).
Resistance to aztreonam, other antibiotics and treatment-emergent microorganisms
Odpornost na aztreonam, druge antibiotike in mikroorganizme, ki se pojavijo med zdravljenjem